← Alle mensen

CL

Chiara Lambertini

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patients.

Journal of the National Cancer Institute · 1 november 2025

Overleving met trastuzumab-emtansine bij residueel HER2-positief mammacarcinoom: KATHERINE definitieve OS

The New England journal of medicine · 16 januari 2025

Atezolizumab plus neoadjuvante anti-HER2 en chemotherapie bij HER2-positief mammacarcinoom: IMpassion050 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2022

T-DM1 plus atezolizumab versus T-DM1 plus placebo bij eerder behandeld HER2-positief mammacarcinoom: KATE2 fase II

The Lancet. Oncology · 2020-10